← Back to Search

Harness Support During Walking for Cerebral Palsy

N/A
Recruiting
Led By Katherine Steele, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No surgery within the last 9 months
8-17 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-time research visit (15 minutes)
Awards & highlights

Study Summary

This trial will help to understand why people with cerebral palsy have such high energy costs when walking, in order to develop better treatments.

Who is the study for?
This trial is for children aged 8-17 with bilateral cerebral palsy, specifically those who can walk and have a certain level of motor function. They should not have had recent surgery or muscle spasm treatments and must be able to understand instructions.Check my eligibility
What is being tested?
The study tests how different levels of harness support affect the energy used by children with CP while walking. It aims to understand why walking consumes more energy for them and will measure oxygen use during various walking tasks.See study design
What are the potential side effects?
Since this trial involves non-invasive procedures like walking with harness support, there are minimal expected side effects, primarily related to physical exertion such as potential fatigue or discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I haven't had surgery in the last 9 months.
Select...
I am between 8 and 17 years old.
Select...
I have moderate motor function difficulties.
Select...
I have been diagnosed with cerebral palsy affecting both sides of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-time research visit (15 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and one-time research visit (15 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxygen
Secondary outcome measures
Lower Extremity
Passive joint range of motion
Selective motor control
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Typically Developing Children (Controls)Experimental Treatment1 Intervention
Children meeting inclusion/exclusion criteria without a diagnosis of cerebral palsy or other condition.
Group II: Children with Cerebral Palsy (Cases)Experimental Treatment1 Intervention
Children meeting inclusion/exclusion criteria with a diagnosis of cerebral palsy.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,726 Total Patients Enrolled
10 Trials studying Cerebral Palsy
1,164 Patients Enrolled for Cerebral Palsy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,757 Total Patients Enrolled
29 Trials studying Cerebral Palsy
8,718 Patients Enrolled for Cerebral Palsy
Gillette Children's Specialty HealthcareOTHER
30 Previous Clinical Trials
11,462 Total Patients Enrolled
13 Trials studying Cerebral Palsy
5,841 Patients Enrolled for Cerebral Palsy

Media Library

Varying levels of harness support during walking Clinical Trial Eligibility Overview. Trial Name: NCT04303078 — N/A
Cerebral Palsy Research Study Groups: Children with Cerebral Palsy (Cases), Typically Developing Children (Controls)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this experiment currently underway?

"Unfortunately, per information on clinicaltrials.gov this specific trial is not presently looking for participants. This study was initially posted to the database November 1st 2022 and last updated August 22nd 2022; however, there are 154 other trials actively recruiting right now."

Answered by AI

Does this trial accept participants beyond the age of thirty?

"This study necessitates that applicants are between 8 and 17 years old. There is a total of 140 medical trials being conducted for minors, as well as 26 clinical studies targeting the elderly population."

Answered by AI

Might I be qualified for enrolling in this experiment?

"This trial looks to enrol 40 individuals aged 8-17 with a diagnosis of cerebral palsy. To qualify, they must meet the GMFCS Level II criteria and not have undergone surgery in the last 9 months or had botulinum toxin/phenol injections in the past 2 months. Furthermore, any potential participants should possess an ability to understand instructions given by researchers."

Answered by AI
~16 spots leftby Dec 2024